Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women. 2001

A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
Eva Perón Hospital, Rosario, Argentina.

This randomized, double-blind, multicenter placebo-controlled study was conducted to investigate the efficacy and tolerability of policosanol, a cholesterol-lowering drug purified from sugar cane wax, in women who had experienced menopause and showed elevated serum total cholesterol and low density lipoprotein (LDL)-cholesterol levels despite a 6-week standard lipid-lowering diet. Thus, 56 eligible patients were randomized to receive placebo or policosanol 5 mg/day for 8 weeks and the dose was doubled to 10 mg/day during the next 8 weeks. Policosanol (5 and 10 mg/day) significantly decreased LDL-cholesterol (17.3% and 26.7%, respectively), total cholesterol (12.9% and 19.5%) as well as the ratios of LDL-cholesterol to high-density lipoprotein (HDL)-cholesterol (17.2% and 26.5%) and total cholesterol to HDL-cholesterol (16.3% and 21.0%) compared with baseline and placebo. HDL-cholesterol levels were significantly raised by 7.4% at study completion. No significant changes occurred in the lipid profile of the placebo group. The drug was safe and well tolerated. No drug-related adverse effects were observed. None of the patients administered policosanol but three of those administered placebo withdrew from the trial because of adverse effects: one due to a serious hypertensive status, one because of an allergic reaction (pruritus plus skin rash) and one due to gastrointestinal disturbances (nauseas plus vomiting). Eleven placebo patients reported 24 adverse effects compared with six policosanol patients who reported seven adverse effects (p < 0.05). In addition, five placebo (17.9%) and 13 policosanol patients (46.4%) (p < 0.05) reported improvements in habitual symptoms and health perception during the study. In conclusion, policosanol was effective and well tolerated in hypercholesterolemic postmenopausal women, showing additional benefits in the health perception of the study patients.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005233 Fatty Alcohols Usually high-molecular-weight, straight-chain primary alcohols, but can also range from as few as 4 carbons, derived from natural fats and oils, including lauryl, stearyl, oleyl, and linoleyl alcohols. They are used in pharmaceuticals, cosmetics, detergents, plastics, and lube oils and in textile manufacture. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Fatty Alcohol,Alcohol, Fatty,Alcohols, Fatty
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic

Related Publications

A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
January 1992, Clinical therapeutics,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
January 1992, Clinical therapeutics,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
September 2005, The Annals of pharmacotherapy,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
March 1999, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
September 2007, Menopause international,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
June 2000, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
January 2000, Maturitas,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
June 2004, Metabolism: clinical and experimental,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
January 1998, Journal of medicine,
A Mirkin, and R Mas, and M Martinto, and R Boccanera, and A Robertis, and R Poudes, and A Fuster, and E Lastreto, and M Yañez, and G Irico, and B McCook, and A Farré
October 2000, Calcified tissue international,
Copied contents to your clipboard!